Three retrospective studies of patients with colorectal carcinoma both found that a B2M mutation was more likely to happen in the microsatellite instability-high (MSI-H) patients and the B2M status was not associated with tumor immune infiltration (60–62). The gene discussed is B2M; the disease is neoplasm.